Datasets
Buyer room
RATEGLP1.COMManage supplier listing
Rate GLP-1 (rateglp1.com) — Monthly-frozen GLP-1 telehealth price index across 43 providers in three lanes - compounded tirzepatide (35 providers), compounded semaglutide (34) and oral GLP-1s (15) - where each provider contributes exactly one normalised figure: its cheapest plan that actually includes the medication, normalised to one month and inclusive of any mandatory membership fee, at the starting dose for dose-dependent pricing. Beneath the index sits a per-provider editorial plan record listing every plan a provider publishes with the captured price, capture date and the exact page it …
supplier index read from their site
Monthly-frozen GLP-1 telehealth price index across 43 providers in three lanes - compounded tirzepatide (35 providers), compounded semaglutide (34) and oral GLP-1s (15) - where each provider contributes exactly one normalised figure: its cheapest plan that actually includes the medication, normalised to one month and inclusive of any mandatory membership fee, at the starting dose for dose-dependent pricing. Beneath the index sits a per-provider editorial plan record listing every plan a provider publishes with the captured price, capture date and the exact page it was read on; a machine-readable JSON endpoint publishes the series, and manufacturer direct-pay brand floors (Zepbound and Wegovy by dose) are tracked as a separate benchmark. A consumer review layer sits alongside
Coverage Health CareAsset class EquitiesTickers LLY · NVO · HIMS
Sample, licence terms, pricing and eval results when Rateglp1 publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about Rateglp1, answered from this page.
Rate GLP-1 (rateglp1.com) — Monthly-frozen GLP-1 telehealth price index across 43 providers in three lanes - compounded tirzepatide (35 providers), compounded semaglutide (34) and oral GLP-1s (15) - where each provider contributes exactly one normalised figure: its cheapest plan that actually includes the medication, normalised to one month and inclusive of any mandatory membership fee, at the starting dose for dose-dependent pricing. Beneath the index sits a per-provider editorial plan record listing every plan a provider publishes with the captured price, capture date and the exact page it …
Rateglp1 offers (Alternative, Price, Sentiment) — One frozen monthly index row across 3 lanes plus 43 provider plan records per cycle (84 provider-lane observations in September 2026: 35 + 34 + 15), each provider record holding every published plan with price, date and source page, plus brand dose ladders for the two manufacturer self-pay channels. At monthly cadence that is roughly 1,000 provider-lane observations per year plus the underlying plan-level records.
Clean price-index construction where introductory pricing has been systematically removed (the single biggest source of error in this market); oral-versus-injectable lane comparison as a distinct product category rather than folded into one number; spread and distribution analysis (cheapest, median, and the most-expensive-provider's-cheapest-plan bound); provider entry and exit tracking via directory liveness and comparable-price eligibility; frozen monthly archives for audit and backtesting; manufacturer-direct-versus-compounded price-gap tracking by dose; consumer review text for satisfaction and churn signal
Coverage spans US; Pharmaceutical Companies, Health Care Services; alternative, price, sentiment; equities.
Rateglp1 has not added their own details yet. Not yet on file: